Brief: Mauna Kea: Positive Results On Needle-Based Endomicroscopy For Real-Time Diagnosis And Staging Of Lung Cancer
May 6 (Reuters) - MAUNA KEA TECHNOLOGIES SAS MKEA.PA :
* MAUNA KEA TECHNOLOGIES ANNOUNCES POSITIVE RESULTS ON NEEDLE-BASED ENDOMICROSCOPY FOR
REAL-TIME
DIAGNOSIS AND STAGING OF LUNG CANCER
* LUNG CANCER CHARACTERISTICS CAN BE ACCURATELY RECOGNIZED WITH CELLVIZIO® AQ-FLEX™ 19
CONFOCAL
MINIPROBE™ USED THROUGH FINE NEEDLES
Source text for Eikon: ID:nBw8bp1yba
Further company coverage: MKEA.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Mauna Kea Technologies SA
See all newsBrief: Mauna Kea Technologies Confirms Trajectory Toward Profitability By Year-End 2027
Brief: Mauna Kea Technologies Announces Results Of Its Combined General Meeting
French and Benelux stocks-Factors to watch 21 Nov
Brief: Mauna Kea Technologies Receives NMPA Regulatory Approval In China For Its Next-Generation Cellvizio Platform
Europe Research Roundup: Craneware, Croda, Genus